52P: Does timing of immunotherapy infusion influence clinical outcomes in non-small cell lung cancer?I. Furtado, I. Guerreiro, Rosa M. Quinta‐Ferreira et al.|Journal of Thoracic Oncology|2025Cited by 0
Real-world efficacy and toxicity of immunotherapy in elderly patients with lung cancerF. Verdasca, I. Guerreiro, M. Seladas et al.|Journal of Geriatric Oncology|2025Cited by 0